<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03494920</url>
  </required_header>
  <id_info>
    <org_study_id>NTA1601</org_study_id>
    <nct_id>NCT03494920</nct_id>
  </id_info>
  <brief_title>DIRECT-SAFE: A Randomized Controlled Trial of DIRECT Endovascular Clot Retrieval Versus Standard Bridging Thrombolysis With Endovascular Clot Retrieval</brief_title>
  <official_title>DIRECT-SAFE: A Randomized Controlled Trial of DIRECT Endovascular Clot Retrieval Versus Standard Bridging Thrombolysis With Endovascular Clot Retrieval Within 4.5 Hours of Stroke Onset</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Neuroscience Trials Australia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>The Florey Institute of Neuroscience and Mental Health</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Neuroscience Trials Australia</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study will be a multicentre, prospective, randomized, open label, blinded endpoint&#xD;
      (PROBE) phase 3 trial (2 arm with 1:1 randomization) in ischemic stroke patients within 4.5&#xD;
      hours of stroke onset. Randomised patients will be stratified for site of baseline arterial&#xD;
      occlusion into one of three groups: 1. internal carotid artery (ICA) 2. middle cerebral&#xD;
      artery (MCA) 3. basilar artery (BA). Patients will be randomised to either bridging&#xD;
      intravenous thrombolysis with endovascular clot retrieval (ECR), or direct endovascular clot&#xD;
      retrieval.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The DIRECT-SAFE trial will include patients with acute ischemic stroke, who are ≥18 years of&#xD;
      age and are eligible for standard intravenous tPA therapy within 4.5 hours of stroke onset.&#xD;
      Patients will be assessed for large vessel occlusion to determine their eligibility for&#xD;
      randomization into the trial. Eligible vessel occlusions include the internal carotid artery,&#xD;
      basilar artery or middle cerebral artery (M1 or M2). Patients will be consented after large&#xD;
      vessel occlusion is confirmed based on standard care multimodal imaging.&#xD;
&#xD;
      Patients will be recruited in Australia, New Zealand, China, Taiwan, Vietnam, Singapore and&#xD;
      Europe. Randomisation either direct to ECR or standard thrombolytic therapy and ECR shall be&#xD;
      in a 1:1 ratio.&#xD;
&#xD;
      All patients will have a multimodal MR (or CT/CTP at investigator's discretion if MRI not&#xD;
      possible) at 18 to 30 hours post treatment to assess reperfusion, recanalization, ischemic&#xD;
      core growth and hemorrhagic transformation. Final follow up will occur at Day 90.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">April 27, 2018</start_date>
  <completion_date type="Anticipated">May 2023</completion_date>
  <primary_completion_date type="Anticipated">February 2023</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Patients will be randomised to either direct endovascular clot retrieval or to bridging intravenous thrombolysis with endovascular clot retrieval.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
    <masking_description>Blinded core laboratory adjudications of the primary outcome. NIHSS and mRS (secondary outcomes) performed by blinded assessor.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Modified Rankin Scale (mRS)- ordinal analysis</measure>
    <time_frame>3 months</time_frame>
    <description>Modified Rankin Scale (mRS) 0-2 or no change from baseline</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>modified Rankin Scale (mRS)- ordinal analysis</measure>
    <time_frame>3 months</time_frame>
    <description>mRS 0-1 or no change from baseline</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Death</measure>
    <time_frame>3 months</time_frame>
    <description>Death due to any cause</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Angiographic reperfusion</measure>
    <time_frame>Baseline</time_frame>
    <description>Proportion of patients with good angiographic reperfusion (mTICI 2b-3)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Symptomatic intracranial haemorrhage (sICH)</measure>
    <time_frame>24 hours</time_frame>
    <description>Proportion of patients with sICH</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">780</enrollment>
  <condition>Ischemic Stroke</condition>
  <arm_group>
    <arm_group_label>Direct endovascular clot retrieval</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Endovascular clot retrieval (ECR) within 4.5 hours stroke</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Bridging thrombolysis followed by ECR</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Intravenous tPA (at the standard licensed dose of 0.9 mg/kg up to a maximum of 90mg, 10% as bolus and the remainder over 1 hour) followed by ECR</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Direct endovascular clot retrieval</intervention_name>
    <description>Direct endovascular clot retrieval within 4.5 hours of stroke onset</description>
    <arm_group_label>Direct endovascular clot retrieval</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Bridging thrombolysis followed by ECR</intervention_name>
    <description>Bridging thrombolysis followed by ECR within 4.5 hours of stroke onset</description>
    <arm_group_label>Bridging thrombolysis followed by ECR</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Patients presenting with acute ischemic stroke eligible using standard criteria to&#xD;
             receive IV thrombolysis within 4.5 hours of stroke onset&#xD;
&#xD;
          2. Patient's age is ≥18 years&#xD;
&#xD;
          3. Intra-arterial clot retrieval treatment can commence (groin puncture) within 6 hours&#xD;
             of stroke onset.&#xD;
&#xD;
          4. Arterial occlusion on CTA or MRA of the ICA, M1, M2 or basilar artery&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Intracranial hemorrhage (ICH) identified by CT or MRI&#xD;
&#xD;
          2. Rapidly improving symptoms at the discretion of the investigator&#xD;
&#xD;
          3. Pre-stroke mRS score of ≥ 4 (indicating previous disability)&#xD;
&#xD;
          4. Hypodensity in &gt;1/3 MCA territory on non-contrast CT&#xD;
&#xD;
          5. Contra indication to imaging with contrast agents&#xD;
&#xD;
          6. Any terminal illness such that patient would not be expected to survive more than 1&#xD;
             year&#xD;
&#xD;
          7. Any condition that, in the judgment of the investigator could impose hazards to the&#xD;
             patient if study therapy is initiated or affect the participation of the patient in&#xD;
             the study.&#xD;
&#xD;
          8. Pregnant women&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Peter Mitchell, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Melbourne Health</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Bernard Yan, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Melbourne Health</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Liverpool Hospital</name>
      <address>
        <city>Liverpool</city>
        <state>New South Wales</state>
        <zip>2170</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>John Hunter Hospital</name>
      <address>
        <city>New Lambton</city>
        <state>New South Wales</state>
        <zip>2305</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Royal North Shore Hospital</name>
      <address>
        <city>St Leonards</city>
        <state>New South Wales</state>
        <zip>2605</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Royal Brisbane &amp; Women's Hospital</name>
      <address>
        <city>Brisbane</city>
        <state>Queensland</state>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gold Coast University Hospital</name>
      <address>
        <city>Gold Coast</city>
        <state>Queensland</state>
        <zip>4215</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Princess Alexandra Hospital</name>
      <address>
        <city>Woolloongabba</city>
        <state>Queensland</state>
        <zip>4102</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Royal Adelaide Hospital</name>
      <address>
        <city>Adelaide</city>
        <state>South Australia</state>
        <zip>5000</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Monash Medical Centre</name>
      <address>
        <city>Clayton</city>
        <state>Victoria</state>
        <zip>3168</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mobile Stroke Unit</name>
      <address>
        <city>Melbourne</city>
        <state>Victoria</state>
        <zip>3050</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Royal Melbourne Hospital</name>
      <address>
        <city>Melbourne</city>
        <state>Victoria</state>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fiona Stanley Hospital</name>
      <address>
        <city>Murdoch</city>
        <state>Western Australia</state>
        <zip>6150</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sir Charles Gairdner Hospital</name>
      <address>
        <city>Nedlands</city>
        <state>Western Australia</state>
        <zip>6009</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Shantou Central Hospital</name>
      <address>
        <city>Shantou</city>
        <state>Guangdong</state>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cangzhou Central Hospital</name>
      <address>
        <city>Cangzhou</city>
        <state>Hebei</state>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wuhan Central Hospital</name>
      <address>
        <city>Wuhan</city>
        <state>Hubei</state>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The 4th Affiliated Hospital of CMU</name>
      <address>
        <city>Shenyang</city>
        <state>Liaoning</state>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Linyi People's Hospital</name>
      <address>
        <city>Linyi</city>
        <state>Shandong</state>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Shanxi People's Hospital</name>
      <address>
        <city>Shanxi</city>
        <state>Taiyuan</state>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Beijing Fengtai Youanmen Hospital</name>
      <address>
        <city>Beijing</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Beijing Tiantin Hospital</name>
      <address>
        <city>Beijing</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Yunfu People's Hospital</name>
      <address>
        <city>Guangdong</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Shiyan Taihe Hospital</name>
      <address>
        <city>Hubei</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ningxiang People's Hospital</name>
      <address>
        <city>Hunan</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>China-Japan Union Hospital of Jilin University</name>
      <address>
        <city>Jilin</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Maoming People's Hospital</name>
      <address>
        <city>Maoming</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Binzhou People's Hospital</name>
      <address>
        <city>Shandong</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Shunde Hospital of Southern Medical University</name>
      <address>
        <city>Shunde</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Jingjiang People's Hospital</name>
      <address>
        <city>Taizhou</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tianjin TEDA Hospital</name>
      <address>
        <city>Tianjin</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Singapore General Hospital</name>
      <address>
        <city>Singapore</city>
        <zip>169608</zip>
        <country>Singapore</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bach Mai Hospital</name>
      <address>
        <city>Hanoi</city>
        <country>Vietnam</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Military Hospital 103</name>
      <address>
        <city>Hanoi</city>
        <country>Vietnam</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>115 People's Hospital</name>
      <address>
        <city>Ho Chi Minh City</city>
        <country>Vietnam</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Australia</country>
    <country>China</country>
    <country>Singapore</country>
    <country>Vietnam</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>April 4, 2018</study_first_submitted>
  <study_first_submitted_qc>April 4, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">April 11, 2018</study_first_posted>
  <last_update_submitted>July 27, 2021</last_update_submitted>
  <last_update_submitted_qc>July 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 29, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Stroke</keyword>
  <keyword>Ischemia</keyword>
  <keyword>Cerebral Infarction</keyword>
  <keyword>Cerebrovascular Disorders</keyword>
  <keyword>Brain Diseases</keyword>
  <keyword>Central Nervous System Diseases</keyword>
  <keyword>Nervous System Diseases</keyword>
  <keyword>Vascular Diseases</keyword>
  <keyword>Cardiovascular Diseases</keyword>
  <keyword>Pathologic Processes</keyword>
  <keyword>Brain Infarction</keyword>
  <keyword>Brain Ischemia</keyword>
  <keyword>Tissue Plasminogen Activator</keyword>
  <keyword>Plasminogen</keyword>
  <keyword>Fibrinolytic Agents</keyword>
  <keyword>Fibrin Modulating Agents</keyword>
  <keyword>Molecular Mechanisms of Pharmacological Action</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Ischemic Stroke</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

